01:57 AM EDT, 08/05/2026 (MT Newswires) -- Thor Medical (TRMED.OL) delivered its first Thorium-228 isotope to an undisclosed customer, according to a Wednesday release. The high-purity isotope was produced at the Norwegian radionuclides supplier's AlphaOne production plant in the Norway-based Heroya Industrial Park. The company added that it expects production from the facility to slowly rise to its target of 21,000 patient dose equivalents after three years.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.